Novartis gets NICE ok for lymphoma CAR-T

UK ' s National Institute for Health and Care Excellence has endorsed Novartis ’ CAR-T therapy, Kymriah, in adult lymphoma patients, after negotiating a deeper discount.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news